Marina Biotech Inc (NASDAQOTH:MRNA)

CAPS Rating: 2 out of 5

A pharmaceutical company, which is focusing on development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology for delivering both small and large molecule drugs.

Recs

1
Player Avatar blaster888 (28.33) Submitted: 12/12/2006 9:45:13 PM : Outperform Start Price: $620.00 MRNA Score: -148.52

Large pipeline of drugs, deal with PG, cash on hand and no debt. Novel delivery system. Potentially huge patent covering analogs of Peptide YY, or peptide derivatives, in the fields of obesity, so that anyone that makes a deal using PYY will have to pay NSTK for it's use.

Report this Post 4 Replies
Member Avatar BIGJIMT (94.02) Submitted: 5/13/2007 7:53:41 PM
Recs: 0

I pumped it in December 2006 and it has gone down. Cramer pumps it in March and it has gone up.
The truth is nstk is the worst nightmare any investor could possibly own. Earnings horrible for 2007 and profit margin is -286% and they have to spend $2 dollars to make $1 dollar. Investors should seek mental help on this stock!

Member Avatar dorfmeister (< 20) Submitted: 5/18/2007 11:08:27 AM
Recs: 0

Another thing you fools do not get is the fact that an alternative route of administrations needs much more of the active ingredient. Therefore you can only win if you have a technology that is able to produce the active ingredients (pth as an example given) much more cheaper then your competitior (lilly's forteo, already priced at 800$ vs. fosamax of 60$). Therefore if you place a bet on "alternative administration of peptides in general" there is only one company that is gonna win: unigene lab.

Member Avatar DrQuay (< 20) Submitted: 11/23/2007 8:32:11 AM
Recs: 0

TOP BULL PITCH IS EXACTLY WHAT JIM CRAMER SPOKE ABOUT FOR 10 MONTHS TO INVESTORS
AFTER 23 YEARS OF EXISTENCE, I NEVER SAW THE LARGE PIPELINE OF DRUGS THAT YOU STATED. DIDN'T AGREE WITH YOUR STATEMENT OF NO DEBT, AND LASTLY I NEVER SAW A STOCK TOUTED TO DEATH BY JIM CRAMER SINCE HIS SHOW ORIGINALLY AIRED LIKE NSTK.
THE STOCKS DECLINE STARTED WHEN YOU POSTED AND IT WAS CRAMER'S TOUTING THAT BEGAN IN MARCH 2007, THAT KEPT THIS STOCK FROM GOING TO LOW $8 DOLLAR RANGE
AS IT SHOULD HAVE FOR 2007. OF COURSE THE P&G DIVORCE CUT IT DOWN TO WHERE IT
ALMOST BELONGS. MAYBE MANAGEMENT WILL FINALLY BE FORCED TO TURN THIS COMPANY AROUND AND START BEING MORE EFFECTIVE. INCLUDING STOPPING FROM GIVING THEMSELVES RAISES AND MORE STOCK OPTIONS TO SELL!

Member Avatar BIGJIMT (94.02) Submitted: 3/15/2010 10:26:23 AM
Recs: 0

03/15/10 a blockbuster week for MRNA. I am calling for a reversal now and expect the stock to sky rocket with a series of news releases for the next seven days.
update:MARCH 15TH, "MRNA' NEWS RELEASE..........
MDRNA, Inc. Demonstrates the Potential for Greater Efficacy in Cancer With an UsiRNA Combination Approach
ONE OF MANY WITHIN THE NEXT SEVEN DAYS AS I HAVE STATED ON THIS SITE,
EARNINGSWHIPERS, THE STREET.COM , PREDICT WALLSTREET, SEEKINGALPHA,
CNBC, MINNYANVILLE, MRNA MESSAGE BOARD, SOCIAL PICKS,ETC.
UNCANNY AND VERY ACCURATE FOR 4 STRAIGHT YEARS ON 'MRNA'
THIS IS THE OPPORTUNITY FOR ALL SHAREHOLDERS TO TAKE PROFITS AND RUN AS I HAVE STATED FOR PAST 8 WEEKS.
GREED WILL CONSUME THE REST.
BUT NOTHING LASTS FOREVER.
THE MOST ACCURATE FORECASTER ON 'MRNA'/ NSTK FOR 4 YEARS IN A ROW, JIMMY T.
TAKE THE ADVANTAGE, THE OPPORTUNITY TO TAKE BIG PROFITS AND MOVE ON TO BETTER QUALITY STOCKS AND THE NEXT LEVEL OF ACHIEVEMENTS.

Featured Broker Partners


Advertisement